Moderna Inc (NASDAQ:MRNA) faces a significant decrease in revenue and net income, reflecting a 91% drop in total revenue and a substantial net loss in Q1 2024 compared to Q1 2023. Despite financial ...
14 minutes ago
Investing.com
Earnings call: Moderna reports a net loss of $12.2 billion By Investing.com
1 day ago
Simply Wall St. via Yahoo
Moderna First Quarter 2024 Earnings: Beats Expectations
19 hours ago
Motley Fool via Yahoo
Why Moderna Stock Blasted 13% Higher Today
Benzinga via Yahoo
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025 Formula, Stock Soars
Fortune via Yahoo
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Pharmaceutical Technology via Yahoo
Moderna reports $1.2bn net loss in Q1 2024
21 hours ago
Black Enterprise
Moderna Stock Takes Minimal Hit After New COVID Vaccine Topped Projected Estimates
17 hours ago
Investor's Business Daily
Moderna Puts Up Big Quarterly Beat; Could Shares Break Out?
2 days ago
Barrons.com
Moderna Stock Jumps After Scoring an Earnings Beat. Next Up? Its RSV Shot.
View all
American biotechnology company
modernatx.com
Moderna, Inc. is a pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. Wikipedia
More on Yahoo Finance